Conduit Pharma (NASDAQ: CDT), that disaster of a despac, up 80% on speculation

Conduit Pharmaceuticals (NASDAQ: CDT) stock has had the sort of entrance to the public markets that gives even the Spac and despac process a bad name. CDT stock has been on Nasdaq for less than a month now and is already down 90%. What a wonderful advertisement for being able to avoid the IPO process that is. Of course, it’s also up that 80% this morning but we think we’d predict that fading. In fact it’s faded back to 70% up in just the time it took to type out that sentence. 

The business line: “Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It’s pipeline includes AZD1656 for the treatment of hashimoto’s thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility” Well, could be good, might not be. Depends upon how those research programs work out. It’s pretty early to tell as the company was only founded in 2019.

tim

Conduit Pharmaceuticals stock price from Google Finance

The original Spac was Murphy Canyon Acquisition and the combination got going in late September. The arrival on Nasdaq, with that ringing the opening bell, was Oct 6th. As we can see it’s been pretty much all downhill from there: down 40% on that debut.

There’s no obvious news over the weekend to tell us that the price should be higher. Certainly nothing to justify 80% up. So, it could be a more general change in attitudes to Canyon Pharma. But we tend not to believe those stories, not with this size of price change. Our best guess - and it’s an informed best guess too - is simply that there’s a little flurry of speculative interest which has led to a momentum trade developing. The very thin markets of the early morning can lead to very large price changes from modest alterations in share buying. We therefore expect this to fade back during the day. As. in fact, is already happening. By the time we’ve got to typing this sentence it’s only 62% up. A flurry of speculation no more we’d say.